...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith-Oncology Pipeline

Such an impressive Pipeline and NO IPO. Why not?

Or is this all window dressing? Doesn't appear so!

And where is this all going? What's it going to take?

 

https://www.zenithepigenetics.com/programs/pipeline

 

A head-scratcher alright ... Koo

Share
New Message
Please login to post a reply